Table 1. Relevance between LpMab-23 reactivity and clinical/pathological features.
| Clinical/pathological features | LpMab-23 reactivity | ||||
|---|---|---|---|---|---|
| Dull and Negative | Positive | P-value | |||
| No. | % | No. | % | ||
| All patients | 29 | 48.3 | 31 | 51.7 | NS |
| Gender | |||||
| Male | 16 | 26.7 | 17 | 28.3 | NS |
| Female | 13 | 21.7 | 14 | 23.3 | |
| Age | |||||
| <66 | 18 | 30 | 15 | 25 | NS |
| ≥66 | 13 | 21.7 | 14 | 23.3 | |
| T-classification | |||||
| T1 | 11 | 18.3 | 18 | 30 | NS |
| T2 | 18 | 30 | 13 | 21.7 | |
| Histological grading | |||||
| Grade 1 | 15 | 25 | 14 | 23.3 | NS |
| Grade 2, 3 | 14 | 23.3 | 17 | 28.3 | |
| Mode of invasion | |||||
| YK-1, 2, 3 | 27 | 45 | 15 | 25 | P<0.01 |
| YK-4C | 2 | 3.3 | 12 | 20 | |
| YK-4D | 0 | 0 | 4 | 6.7 | |
| Local recurrence | |||||
| No | 26 | 43.3 | 31 | 51.7 | NS |
| Yes | 3 | 5 | 0 | 0 | |
| Late cervical lymph node metastasis | |||||
| No | 28 | 46.7 | 18 | 30 | P<0.01 |
| Yes | 1 | 1.7 | 13 | 21.7 | |
NS, not significant. Ratio was rounded off to the 1st decimal place.